Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014807 |
| CAS No | 109095-35-4 (free base) |
| Mol.F. | C19H21ClN4OS |
| Mol.Wt. | 388.9 |
| INV STATUS | In Stock |
| CAT No | SRC-N014808 |
| CAS No | NA |
| Mol.F. | C12H7ClN2OS |
| Mol.Wt. | 262.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014809 |
| CAS No | NA |
| Mol.F. | C11H7N5O3 |
| Mol.Wt. | 257.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014810 |
| CAS No | NA |
| Mol.F. | C11H5Cl2N5O |
| Mol.Wt. | 294.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014811 |
| CAS No | NA |
| Mol.F. | C20H13ClN6O2 |
| Mol.Wt. | 404.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014812 |
| CAS No | NA |
| Mol.F. | C11H6BrClN6O |
| Mol.Wt. | 353.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014813 |
| CAS No | NA |
| Mol.F. | C29H20BrN7O3 |
| Mol.Wt. | 594.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014814 |
| CAS No | NA |
| Mol.F. | C20H14ClN7O2 |
| Mol.Wt. | 419.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014815 |
| CAS No | NA |
| Mol.F. | C20H14BrN7O3 |
| Mol.Wt. | 480.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014816 |
| CAS No | NA |
| Mol.F. | C20H15N7O2 |
| Mol.Wt. | 385.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014817 |
| CAS No | NA |
| Mol.F. | C21H14BrN5O2 |
| Mol.Wt. | 448.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014818 |
| CAS No | 26360-21-4 |
| Mol.F. | C19H18N8O7 |
| Mol.Wt. | 470.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014819 |
| CAS No | NA |
| Mol.F. | C20H20N8O8 : Ca |
| Mol.Wt. | 500.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014820 |
| CAS No | NA |
| Mol.F. | C20H21N8O8 : Ca |
| Mol.Wt. | 501.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014821 |
| CAS No | NA |
| Mol.F. | C20H21N8O8 : Ca |
| Mol.Wt. | 501.4 : 40.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014822 |
| CAS No | NA |
| Mol.F. | C17H20N12O8 |
| Mol.Wt. | 520.4 |
| INV STATUS | CUSTOM SYNTHESIS |